Go to content
UR Home

Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice

URN to cite this document:
urn:nbn:de:bvb:355-epub-479069
DOI to cite this document:
10.5283/epub.47906
Harloff, Manuela ; Prüschenk, Sally ; Seifert, Roland ; Schlossmann, Jens
Date of publication of this fulltext: 30 Aug 2021 10:34


Abstract

Background and Purpose Diabetic nephropathy is the leading cause for end-stage renal disease worldwide. Until now, there is no specific therapy available. Standard treatment with inhibitors of the renin-angiotensin system just slows down progression. However, targeting the NO/sGC/cGMP pathway using sGC activators does prevent kidney damage. Thus, we investigated if the sGC activator cinaciguat ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 4239

Dissertations: dissertationen@ur.de
0941 943 3904

Research data: daten@ur.de
0941 943 4239

Contact persons